Phone text program to help people with HIV in Uganda and Zambia stop smoking
Official title: Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia
Funded at Univ of Maryland, College Park · NIH-11418843 · Data updated 2026-11-12
This program uses tailored text messages and nicotine patches to help people living with HIV in Uganda and Zambia quit tobacco.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Maryland, College Park NIH-funded |
| Lab location | 1 site (College Park, United States) |
| Project start | September 15, 2021 |
| Project end | August 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $272,847 |
| NIH project number | 3U01CA261624-05S1 |
| Project ID | NIH-11418843 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV who currently use tobacco and receive care at participating HIV clinics in Uganda or Zambia are the ideal candidates.
✕Less likely to help
People who do not use tobacco, live outside Uganda or Zambia, or are not engaged in HIV care at participating clinics would not benefit from this program.
What this research studies
If you join, you will be randomly assigned to receive either tailored SMS support, brief advice to quit, or nicotine patches while staying in HIV care at local clinics. The text messages are written to address challenges common for people with HIV such as depression, alcohol use, lack of awareness about smoking risks, and stigma. Researchers will follow up by phone and at the clinic to see whether you remain tobacco-free six months after starting. The goal is to find an affordable, clinic-deliverable way to help people with HIV stop using tobacco.
Why it matters
Potential benefit: If successful, the program could help people with HIV stop smoking and reduce tobacco-related illness and deaths in Uganda and Zambia.
How similar studies have gone: Phone-text and nicotine patch approaches have helped smokers in general populations, but this tailored SMS program for people living with HIV in sub-Saharan Africa is new and being tested in a randomized trial.
Where this research is happening
-
Univ of Maryland, College Park
College Park, United States Active
Researchers
- Principal investigator: Wipfli, Heather L — Univ of Maryland, College Park
- Study coordinator: Wipfli, Heather L
Related research
Other NIH-funded projects on the same topics.
-
Tobacco quitting support for people living with HIV in Kisumu County, Kenya
This project brings tobacco‑cessation help into HIV clinics so people living with HIV in Kisumu can get counseling and support to quit tobacco.
-
Helping people living with HIV in Uganda and Zambia quit smoking using phone-based support.
This study is testing a helpful phone program that sends supportive text messages to people living with HIV in Uganda and Zambia to help them quit smoking, comparing it to regular care like advice and nicotine patches.
-
Helping people with HIV quit tobacco in Kenya
This study is testing a new way to help people living with HIV in Kenya quit smoking by adding support programs right into their regular HIV care, making it easier for them to stop using tobacco and improve their health.
-
Ending Tobacco Use with a Smartphone Program for Cambodian People Living with HIV/AIDS
A smartphone-based quit-smoking program designed for people living with HIV/AIDS in Cambodia to help reduce tobacco use alongside HIV treatment.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
-
How deforestation affects alcohol and tobacco use in Indonesia
This project looks at whether forest loss in Indonesia is linked to changes in people's tobacco and alcohol use across different places and years.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.